Keyword: AbbVie

News

Express Scripts to List Dariprim Alternative for $1

02.12.2015 - Express Scripts Holding, the biggest pharmacy benefits manager in the US, said it plans to list Imprimis Pharmaceuticals’ cheaper alternative to the toxoplasmosis treatment...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

Markets & Companies

Leaving the Patent Cliff Behind

07.10.2015 - The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...

News

United Therapeutics Sells Priority Review Voucher to AbbVie

21.08.2015 - US biotechnology company United Therapeutics has agreed to sell its Rare Pediatric Disease Priority Review Boucher (PPRV) to a subsidiary of biopharmaceutical firm AbbVie for $350...

News

Celgene Offers $7.2 Billion for Receptos

17.07.2015 - US biotech firm Celgene has agreed to pay $7.2 billion, or $232 per share, to acquire compatriot Receptos, a biotech company that makes a potential blockbuster drug to treat...

News

AbbVie Completes Pharmacyclics Acquisition

28.05.2015 - AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...

News

PwC Sees Pharmaceuticals, Life Sciences in M&A Surge

18.05.2015 - The pharmaceuticals and life sciences sectors saw 35 mergers and acquisitions worth $166.3 billion in the first three months of 2015, a value that eclipsed transactions from all of...

News

AbbVie and Puerto Rico Announce $30 Million Expansion

20.03.2015 - AbbVie is expanding an existing site in Puerto Rico at a cost of $30 million, adding to its capacity for biotechnology. The proposed expansion will take place in AbbVie's site...